GENE ONLINE|News &
Opinion
Blog

US BIO 2024
AusBiotech on Funding, Regulatory Navigation, International Expansion, and Clinical Trial Development in Australia’s Biotech Industry
2024-08-22
Taiwan’s Biotech Innovations Draw International Attention at BIO 2024
2024-06-26
Taiwan’s Biotech and Pharma Delegation: Innovations Take Center Stage at BIO 2024
2024-06-21
Merck Buys EyeBio for $3B and Shares Global Policy Perspectives During BIO in San Diego
2024-06-20
Johnson & Johnson’s Bispecific Antibodies for Atopic Dermatitis and Talks of Biotech Partnerships at BIO 2024
2024-06-20
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
2024 Agri-Biotechnology Leadership Awards Announced at BIO in San Diego
2024-06-11
KriSan Biotech Expands ADC CrDMO Services to Global Biotech Companies
2024-06-04
JelloX Biotech Present Digital Health Solutions at 2024 U.S. BIO Convention in San Diego
2024-06-04
BIO 2024 Showcases the Emergence of Taiwan’s Biotech CDMO Market
2024-06-04
Taiwan Biotech Forum Kicks Off in San Diego Ahead of BIO 2024
2024-06-03
Taiwan Biotech Delegation Leads International Exchange with Phoenix Biotech Community and Mayo Clinic
2024-05-29
1 2
LATEST
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
Healthcare Revolution: Leeuwenhoek Joins Hands with Key Companies and Experts at Healthcare+ Expo Taiwan 2024
2024-12-11
2024 Taiwan Healthcare+ Expo: Innovations in Five Key Industries
2024-12-11
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
EVENT
Scroll to Top